Please select an option below to help us tailor your newsletter to best suit your content interests!
Join Us for the 10th Annual West Oncology Conference Date: Saturday – Sunday, February 8-9, 2025 Location: Hilton Memphis Hosted by Total Health Conferencing Our West Oncology Conference is back for the 10th year, bringing cutting-edge oncology research and education to the forefront! This accredited event offers 7.5 CE/CME Credits & MOC points, and features… Read more »
Exciting News! Dr. Clay Jackson presented preliminary validation findings for a brand-new screening tool at #GSA2024 designed to help caregivers with early identification of agitation in Alzheimer’s dementia. This innovative screener has global implications for improving the quality of care for those impacted by this challenging disease. Together, we’re making strides toward a brighter future… Read more »
Dr. Richard Fine, one of our exceptional breast surgeons, is actively involved in groundbreaking research shaping the future of breast cancer care. An FDA panel has endorsed the use of the ProSense cryoablation system as a less-invasive alternative to surgery for some early-stage, low-risk breast cancer patients. This technology uses extreme cold to destroy tumors,… Read more »
Appointments Providers Patient Portal Mobile Clinic West Cancer Center & Research Institute is excited to announce the expansion of its wellness division through the acquisition of Lifesigns, beginning January 1, 2024. Dr. Bill West’s vision of outstanding patient care in this community is reflected in both centers. As the founder of West in 1979 and... Read more »
November is here, and so is Men’s Health Awareness Month! 💙 Join us as we support West Cancer Foundation in promoting men’s health and wellness. Don’t miss the opportunity to take charge of your health by attending their FREE Community Health Fair next week—featuring vital prostate screenings. Early detection is key! 📅 Mark your calendars,… Read more »
Advancements in ROS1-Positive Non-Small Cell Lung Cancer A recent article from CURE Today highlights the progress being made in targeted therapies for this rare subtype of lung cancer, which affects around 1-2% of patients. Our West family is proud to be at the forefront of this critical work, where Dr. Jason Porter and his team… Read more »